VSMC phenotype regulation was ascertained by histological measurement of myocardin localization, showing that AngII treatment resulted in a reduced nuclear myocardin fraction in the media, independent of AAA formation (Figure 6a). The gene discussed is AGT; the disease is triple-A syndrome.